{"title":"综合治疗降低IgG4相关硬化性肠系炎患者血清IgG4: 1例报告","authors":"Yu-Xiang Wang, Chia-Hao Hsu, Kai-Yun Huang, Chien-Ming Yen, His Chen, Yen-Ying Kung, Ching-Mao Chang","doi":"10.1093/qjmed/hcaf163","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the potential effectiveness of Chinese herbal medicine (CHM) as an adjunct to conventional corticosteroid therapy in the management of IgG4-related sclerosing mesenteritis.</p><p><strong>Clinical features and outcome: </strong>A 61-year-old male presented with a two-month history of persistent diarrhea, anorexia, postprandial bloating, and significant weight loss. Diagnostic evaluation, including serum IgG4 measurement and tissue biopsy, confirmed a diagnosis of IgG4-related sclerosing mesenteritis. Despite initial treatment with oral corticosteroids, the patient's serum IgG4 level increased from 1080 mg/dL to 1240 mg/dL, prompting the initiation of integrated therapy with CHM. The patient was treated with a modified CHM regimen primarily composed of San-Tsung-Kuei-Chien-Tang, Zhen-Ren-Huo-Ming-Yin, Wen-Dan-Tang, and Zhu-Ling-Tang. At 217 days after starting CHM, serum IgG4 levels decreased to 606 mg/dL, with marked clinical improvement. Continued CHM therapy further reduced the serum IgG4 concentration to 68 mg/dL, and clinical symptoms remained well controlled without recurrence.</p><p><strong>Conclusions: </strong>Integrated therapy combining CHM with corticosteroid treatment may effectively lower serum IgG4 levels and ameliorate clinical symptoms in IgG4-related sclerosing mesenteritis. Further research is warranted to confirm these findings and clarify the underlying mechanisms.</p>","PeriodicalId":20806,"journal":{"name":"QJM: An International Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":6.4000,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Integrated therapy reduces serum IgG4 in patients with IgG4-related sclerosing mesenteritis: A Case Report.\",\"authors\":\"Yu-Xiang Wang, Chia-Hao Hsu, Kai-Yun Huang, Chien-Ming Yen, His Chen, Yen-Ying Kung, Ching-Mao Chang\",\"doi\":\"10.1093/qjmed/hcaf163\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To evaluate the potential effectiveness of Chinese herbal medicine (CHM) as an adjunct to conventional corticosteroid therapy in the management of IgG4-related sclerosing mesenteritis.</p><p><strong>Clinical features and outcome: </strong>A 61-year-old male presented with a two-month history of persistent diarrhea, anorexia, postprandial bloating, and significant weight loss. Diagnostic evaluation, including serum IgG4 measurement and tissue biopsy, confirmed a diagnosis of IgG4-related sclerosing mesenteritis. Despite initial treatment with oral corticosteroids, the patient's serum IgG4 level increased from 1080 mg/dL to 1240 mg/dL, prompting the initiation of integrated therapy with CHM. The patient was treated with a modified CHM regimen primarily composed of San-Tsung-Kuei-Chien-Tang, Zhen-Ren-Huo-Ming-Yin, Wen-Dan-Tang, and Zhu-Ling-Tang. At 217 days after starting CHM, serum IgG4 levels decreased to 606 mg/dL, with marked clinical improvement. Continued CHM therapy further reduced the serum IgG4 concentration to 68 mg/dL, and clinical symptoms remained well controlled without recurrence.</p><p><strong>Conclusions: </strong>Integrated therapy combining CHM with corticosteroid treatment may effectively lower serum IgG4 levels and ameliorate clinical symptoms in IgG4-related sclerosing mesenteritis. Further research is warranted to confirm these findings and clarify the underlying mechanisms.</p>\",\"PeriodicalId\":20806,\"journal\":{\"name\":\"QJM: An International Journal of Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":6.4000,\"publicationDate\":\"2025-07-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"QJM: An International Journal of Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/qjmed/hcaf163\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"QJM: An International Journal of Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/qjmed/hcaf163","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Integrated therapy reduces serum IgG4 in patients with IgG4-related sclerosing mesenteritis: A Case Report.
Objectives: To evaluate the potential effectiveness of Chinese herbal medicine (CHM) as an adjunct to conventional corticosteroid therapy in the management of IgG4-related sclerosing mesenteritis.
Clinical features and outcome: A 61-year-old male presented with a two-month history of persistent diarrhea, anorexia, postprandial bloating, and significant weight loss. Diagnostic evaluation, including serum IgG4 measurement and tissue biopsy, confirmed a diagnosis of IgG4-related sclerosing mesenteritis. Despite initial treatment with oral corticosteroids, the patient's serum IgG4 level increased from 1080 mg/dL to 1240 mg/dL, prompting the initiation of integrated therapy with CHM. The patient was treated with a modified CHM regimen primarily composed of San-Tsung-Kuei-Chien-Tang, Zhen-Ren-Huo-Ming-Yin, Wen-Dan-Tang, and Zhu-Ling-Tang. At 217 days after starting CHM, serum IgG4 levels decreased to 606 mg/dL, with marked clinical improvement. Continued CHM therapy further reduced the serum IgG4 concentration to 68 mg/dL, and clinical symptoms remained well controlled without recurrence.
Conclusions: Integrated therapy combining CHM with corticosteroid treatment may effectively lower serum IgG4 levels and ameliorate clinical symptoms in IgG4-related sclerosing mesenteritis. Further research is warranted to confirm these findings and clarify the underlying mechanisms.
期刊介绍:
QJM, a renowned and reputable general medical journal, has been a prominent source of knowledge in the field of internal medicine. With a steadfast commitment to advancing medical science and practice, it features a selection of rigorously reviewed articles.
Released on a monthly basis, QJM encompasses a wide range of article types. These include original papers that contribute innovative research, editorials that offer expert opinions, and reviews that provide comprehensive analyses of specific topics. The journal also presents commentary papers aimed at initiating discussions on controversial subjects and allocates a dedicated section for reader correspondence.
In summary, QJM's reputable standing stems from its enduring presence in the medical community, consistent publication schedule, and diverse range of content designed to inform and engage readers.